Financials data is unavailable for this security.
View more
Year on year Bio Rad Laboratories Inc had revenues fall -4.67% from 2.80bn to 2.67bn, though the company grew net income from a loss of 3.63bn to a smaller loss of 637.32m.
Gross margin | 54.02% |
---|---|
Net profit margin | -51.73% |
Operating margin | 12.97% |
Return on assets | -12.24% |
---|---|
Return on equity | -17.41% |
Return on investment | -12.87% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Bio Rad Laboratories Inc fell by 30.18m. However, the company earned 374.94m from its operations for a Cash Flow Margin of 14.04%. In addition the company generated 20.21m cash from investing, though they paid out 425.65m more in financing than they received.
Cash flow per share | -40.98 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 240.39 |
---|---|
Tangible book value per share | 214.89 |
More ▼
Balance sheet in USDView more
Current ratio | 6.28 |
---|---|
Quick ratio | 4.63 |
Total debt/total equity | 0.1771 |
---|---|
Total debt/total capital | 0.1504 |
More ▼
Growth rates in USD
SmartText is unavailable
EPS growth(5 years) | -- |
---|---|
EPS (TTM) vs TTM 1 year ago | -220.55 |